Interrupted Time Series of User‐centered Clinical Decision Support Implementation for Emergency Department–initiated Buprenorphine for Opioid Use Disorder
Abstract:Objectives
Adoption of emergency department (ED) initiation of buprenorphine (BUP) for opioid use disorder (OUD) into routine emergency care has been slow, partly due to clinicians’ unfamiliarity with this practice and perceptions that it is complicated and time‐consuming. To address these barriers and guide emergency clinicians through the process of BUP initiation, we implemented a user‐centered computerized clinical decision support system (CDS). This study was conducted to assess the feasibility of impleme… Show more
“…However, 1 study found that the rate of ED-initiated buprenorphine only increased when waivered providers also received a clinical decision support system and just-in-time training. 27 Recently trained ED providers are also more likely to believe OUD is similar to other chronic diseases and approve of ED-initiated buprenorphine, highlighting the importance of education in expanding prescribing capacity. 6 Third, interviewees argued that transitions of care for patients with OUD should mirror other ED referrals for high-risk conditions with many suggesting the establishment of a central agency to streamline communication.…”
Section: Discussionmentioning
confidence: 99%
“…not yet have the capacity to schedule appointments.Previous work has leveraged the EHR to provide computerized clinical decision support systems, which have improved rates of buprenorphine prescribing in the ED for patients with untreated OUD 27. Additionally, patient privacy regulations surrounding health information, including patient records for the treatment of substance use disorders as guided by the 42 CFR Part 2 regulations, have recently been revised to facilitate coordination of care 29.…”
Study objective
Opioid use disorder (OUD) is on the rise nationwide with increasing emergency department (ED) visits and deaths secondary to overdose. Although previous research has shown that patients who are started on buprenorphine in the ED have increased engagement in addiction treatment, access to on‐demand medications for OUD is still limited, in part because of the need for linkages to outpatient care. The objective of this study is to describe emergency and outpatient providers’ perception of local barriers to transitions of care for ED‐initiated buprenorphine patients.
Methods
Purposive sampling was used to recruit key stakeholders, identified as physicians, addiction specialists, and hospital administrators, from 10 EDs and 11 outpatient clinics in King County, Washington. Twenty‐one interviews were recorded and transcribed and then coded using an integrated deductive and inductive content analysis approach by 2 team members to verify accuracy of the analysis. Interview guides and coding were informed by the Consolidated Framework for Implementation Research (CFIR), which provides a structure of domains and constructs associated with effective implementation of evidence‐based practice.
Results
From the 21 interviews with emergency and outpatient providers, this study identified 4 barriers to transitions of care for ED‐initiated buprenorphine patients: scope of practice, prescribing capacity, referral incoordination, and loss to follow‐up.
Conclusion
Next steps for implementation of this intervention in a community setting include establishing a standard of care for treatment and referral for ED patients with OUD, increasing buprenorphine prescribing capacity, creating a central repository for streamlined referrals and follow‐up, and supporting low‐barrier scheduling and navigation services.
“…However, 1 study found that the rate of ED-initiated buprenorphine only increased when waivered providers also received a clinical decision support system and just-in-time training. 27 Recently trained ED providers are also more likely to believe OUD is similar to other chronic diseases and approve of ED-initiated buprenorphine, highlighting the importance of education in expanding prescribing capacity. 6 Third, interviewees argued that transitions of care for patients with OUD should mirror other ED referrals for high-risk conditions with many suggesting the establishment of a central agency to streamline communication.…”
Section: Discussionmentioning
confidence: 99%
“…not yet have the capacity to schedule appointments.Previous work has leveraged the EHR to provide computerized clinical decision support systems, which have improved rates of buprenorphine prescribing in the ED for patients with untreated OUD 27. Additionally, patient privacy regulations surrounding health information, including patient records for the treatment of substance use disorders as guided by the 42 CFR Part 2 regulations, have recently been revised to facilitate coordination of care 29.…”
Study objective
Opioid use disorder (OUD) is on the rise nationwide with increasing emergency department (ED) visits and deaths secondary to overdose. Although previous research has shown that patients who are started on buprenorphine in the ED have increased engagement in addiction treatment, access to on‐demand medications for OUD is still limited, in part because of the need for linkages to outpatient care. The objective of this study is to describe emergency and outpatient providers’ perception of local barriers to transitions of care for ED‐initiated buprenorphine patients.
Methods
Purposive sampling was used to recruit key stakeholders, identified as physicians, addiction specialists, and hospital administrators, from 10 EDs and 11 outpatient clinics in King County, Washington. Twenty‐one interviews were recorded and transcribed and then coded using an integrated deductive and inductive content analysis approach by 2 team members to verify accuracy of the analysis. Interview guides and coding were informed by the Consolidated Framework for Implementation Research (CFIR), which provides a structure of domains and constructs associated with effective implementation of evidence‐based practice.
Results
From the 21 interviews with emergency and outpatient providers, this study identified 4 barriers to transitions of care for ED‐initiated buprenorphine patients: scope of practice, prescribing capacity, referral incoordination, and loss to follow‐up.
Conclusion
Next steps for implementation of this intervention in a community setting include establishing a standard of care for treatment and referral for ED patients with OUD, increasing buprenorphine prescribing capacity, creating a central repository for streamlined referrals and follow‐up, and supporting low‐barrier scheduling and navigation services.
“…To address this, one can benefit from points of access to patients to potentially initiating treatments. These include ED visit/hospital admission [ 138 , 139 , 140 , 141 , 142 ] and incarceration [ 143 , 144 , 145 , 146 , 147 , 148 , 149 ]. Employing techniques like screening, brief intervention, and referral to treatment (SBIRT) can also be helpful in this regard [ 75 ].…”
The current opioid epidemic has killed more than 446,000 Americans over the past two decades. Despite the magnitude of the crisis, little is known to what degree the misalignment of incentives among stakeholders due to competing interests has contributed to the current situation. In this study, we explore evidence in the literature for the working hypothesis that misalignment rooted in the cost, quality, or access to care can be a significant contributor to the opioid epidemic. The review identified several problems that can contribute to incentive misalignment by compromising the triple aims (cost, quality, and access) in this epidemic. Some of these issues include the inefficacy of conventional payment mechanisms in providing incentives for providers, practice guidelines in pain management that are not easily implementable across different medical specialties, barriers in adopting multi-modal pain management strategies, low capacity of providers/treatments to address opioid/substance use disorders, the complexity of addressing the co-occurrence of chronic pain and opioid use disorders, and patients’ non-adherence to opioid substitution treatments. In discussing these issues, we also shed light on factors that can facilitate the alignment of incentives among stakeholders to effectively address the current crisis.
“…14 However, a group at Ochsner Clinic demonstrated that the implementation of such a tool in 36 clinics greatly increased the number of patients receiving OUD therapy, and a group at the University of Texas Southwestern has been testing whether an OUD CDS can increase the initiation of buprenorphine treatment in emergency departments. [15][16][17][18] A National Institute on Drug Abuse Center for the Clinical Trials Network (CTN) report in 2020 concluded that a CDS tool for OUD screening, assessment, and treatment might help address the opioid crisis. 19 Our team has extensive experience with building and testing CDS systems and has been working on a version aimed at the CTN recommendations.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.